3 most recent filings and news items mentioning AXSM. Updated every 60 seconds.
LeadershipJun 9, 2026Neutral
Axsome Therapeutics adopted an Executive Severance and Change in Control Plan effective June 5, 2026, to provide severance benefits to key employees upon involuntary termination. The plan supersedes prior severance arrangements and is intended to retain executive talent during or
View filing at SEC.gov →
OptionsJun 5, 2026Neutral
10 Health Care Stocks Whale Activity In Today's Session
View filing at SEC.gov →
LegalJun 3, 2026Positive
Axsome Therapeutics resolved all patent litigation related to SUNOSI (solriamfetol) by settling with the remaining first-to-file generic applicant, allowing five companies to sell generic versions starting September 1, 2040 (or March 1, 2040 if no pediatric exclusivity). The sett
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.